Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02670941 · ClinicalTrials.gov registry record · Early Phase 1
Aromatherapy for Chemotherapy-induced Symptoms
A Early Phase 1 study, sponsored by University of Rochester.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 31
- Enrollment target
NCT02670941 is a Early Phase 1 study that was terminated before completion, run by University of Rochester. The registered enrollment target is 31 participants.
The verdict
NCT02670941, a Early Phase 1 study, was terminated before completion, sponsored by University of Rochester.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 31 participants
- Enrollment target
Study Summary
The rationale behind the proposed study is to determine the initial effectiveness of aromatherapy in relief of commonly reported symptoms in cancer patients undergoing chemotherapy.
Interventions
- DRUG Ginger
- DRUG Lavender
- DRUG Orange
- DRUG Jojoba
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2016-01 |
| Est. Completion | 2018-09-12 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02670941
The ClinicalTrials.gov registry entry for NCT02670941 describes a study currently listed as terminated, categorized as Early Phase 1. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Ginger is the first listed.
NCT02670941 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02670941 about?
NCT02670941 is a clinical study titled "Aromatherapy for Chemotherapy-induced Symptoms". The rationale behind the proposed study is to determine the initial effectiveness of aromatherapy in relief of commonly reported symptoms in cancer patients undergoing chemotherapy.
What is the current status of trial NCT02670941?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 31 participants. The study started on 2016-01. Estimated completion is 2018-09-12.
What interventions are being tested in trial NCT02670941?
The interventions under investigation include: Ginger (DRUG), Lavender (DRUG), Orange (DRUG), Jojoba (DRUG).
Who is sponsoring clinical trial NCT02670941?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.